Abstract:Rationale and Objectives To explore the correlation between the tumor dissemination characteristic at 18 F-fluoro-deoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) images and the outcome of first-line systemic therapy for stage IV non-small cell lung cancer (NSCLC). Materials and Methods The current retrospective study included 101 NSCLC patients receiving first-line systemic therapy with baseline 18 F-FDG PET/CT images available. The distance between the two lesions that were the farthest apart was defined as D max to calculate the tumor dissemination. The tumor metabolic volume (MTV) of the primary tumor and the MTV of the whole-body tumor lesions (MTV wb ) were calculated using 18 F-FDG PET/CT imaging. The Kaplan–Meier survival analyses and Cox predictive model were performed to assess the relationship between the parameters and survival. Results D max and MTV wb were independent prognostic factors for overall survival (OS) ( p = 0.019 and p = 0.011, respectively) and progression-free survival (PFS) ( p = 0.043 and p = 0.009, respectively). Poor PFS and OS were associated with high MTV wb (>54.0 cm 3 ) and high D max (>48.5 cm) ( p = 0.006 and p = 0.008, respectively). When MTV wb and D max were combined, three risk groups were stratified with no (score 0), one (score 1), or two (score 2) factors ( p < 0.001 for PFS, p < 0.001 for OS). The group with a score of 0 had a considerably longer PFS and OS than those who received a score of 1 or 2 (PFS: 61.1%, 43.5%, and 21.1%, respectively, OS: 77.8%, 54.3%, and 36.8%, respectively). Conclusion The combination of tumor dissemination characteristic (D max ) and tumor burden (MTV wb ) can further improve the prognosis stratification of NSCLC.

FDG PET/CT Tumor Dissemination Characteristic Predicts the Outcome of First-Line Systemic Therapy in Non-small Cell Lung Cancer